As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions

The cover story in last week’s issue of The Cancer Letter featured a retraction of a Nature Medicine paper demonstrating that giving patients immunochemotherapy before 3:00 p.m. led to massive improvements in overall survival and progression-free survival.

July 15, 2026

Vol.52 No.27

News Analysis

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

On Feb. 2, Nature Medicine published the results of a large, randomized, prospective clinical trial in the nascent and some say, fringe, field of chrono-oncology—the study of how natural biological rhythms might impact cancer outcomes.

Ned Sharpless’s portrait unveiled at FNIH ceremony

Former NCI director Norman “Ned” Sharpless had his portrait unveiled at a ceremony hosted by the Foundation for the National Institutes of Health on the main NIH campus in Bethesda.

July 10, 2026

Vol.52 No.27

Podcast The Directors

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

How’s this for a paradox: The better cancer centers become at keeping patients alive, the more expensive cancer care becomes. This brutal tradeoff hits harder in rural areas, where the cancer burden is higher and the investigator and clinical trial representation is lower.

June 26, 2026

Vol.52 No.25

By Paul Goldberg and Claire Marie Porter

Cancer Policy

Early-onset cancer bill introduced in Congress

Asal SayasSen. Ed Markey (D-MA) and Sen. Amy Klobuchar (D-MN) introduced a bill that requires NIH to develop a national strategy to address the rise of cancer in younger adults.

NCI renews the UC San Diego Moores CCSG, committing $25M

University of California San Diego Moores Cancer Center has received a five-year, $25 million Cancer Center Support Grant from NCI.

June 18, 2026

Vol.52 No.24

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab

The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

YOU MAY BE INTERESTED IN

Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

Ned Sharpless’s portrait unveiled at FNIH ceremony

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”

Early-onset cancer bill introduced in Congress

NCI renews the UC San Diego Moores CCSG, committing $25M

Renew today!

Subscriber content

Never miss an issue!

Login

As his Senate testimony alleged danger from mRNA COVID vaccine, El-Deiry had an offer to run NCI Frederick lab

The job offer to run the lab—home to virus research, RAS Initiative, and data science—was quickly rescinded

YOU MAY BE INTERESTED IN

Did peer review fail? Nature Medicine’s chronotherapy paper retraction raises questions

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

Ned Sharpless’s portrait unveiled at FNIH ceremony

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas“Institutions are feeling crunched in so many different directions”

Early-onset cancer bill introduced in Congress

NCI renews the UC San Diego Moores CCSG, committing $25M

Never miss an issue!

Login

A chronotherapy study in Nature Medicine showed dramatic results. Then it was retracted.
The phase III trial claimed a staggering boost to OS and PFS when immunochemotherapy was given before 3 p.m.

The Directors: Directors of two Midwestern cancer centers tell us about the challenging healthcare economics in rural areas
“Institutions are feeling crunched in so many different directions”